Use of F-652 in Patients With Alcoholic Hepatitis
Condition(s):Alcoholic HepatitisLast Updated:September 9, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Alcoholic HepatitisLast Updated:September 9, 2019Completed
Condition(s):Acute B Lymphoblastic Leukemia; Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:May 18, 2022Recruiting
Condition(s):ACL Injury; Muscle Weakness; Neuromuscular ManifestationsLast Updated:February 21, 2023Completed
Condition(s):Liver TransplantationLast Updated:July 23, 2019Unknown status
Condition(s):End Stage Renal DiseaseLast Updated:October 8, 2019Completed
Condition(s):Kidney TransplantationLast Updated:March 21, 2006Completed
Condition(s):Exocrine Pancreatic Insufficiency; Weight GainLast Updated:December 18, 2023Recruiting
Condition(s):Myelodysplastic Syndrome; Hodgkin’s Lymphoma; Non-Hodgkin’s Lymphoma; Acute Leukemia; Multiple MyelomaLast Updated:March 27, 2024Recruiting
Condition(s):Abdominal Aortic Aneurysm; Surgery; Arterial DiseaseLast Updated:February 20, 2024Active, not recruiting
Condition(s):Cataract; Corneal Endothelial Keratopathy; Phacoemulfisication+IOL Implantation; Endothelial KeratopathyLast Updated:April 29, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.